Syros Pharmaceuticals to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company
pioneering the development of medicines to control the expression of
disease-driving genes, today announced that members of its management
team will present at upcoming investor conferences. Details are as
follows:

Cowen and Company 37^th Annual Health Care
Conference
Date: Wednesday, March 8
Presentation Time:
11:20 a.m. ET
Location: Boston Marriott Copley Place, 110
Huntington Avenue, Boston, MA

Oppenheimer 27th Annual Healthcare Conference
Date:
Wednesday, March 22
Presentation Time: 2:10 p.m. ET
Location:
The Westin New York Grand Central, 212 East 42nd Street, New York, NY

A live webcast of each presentation will be available on the News &
Investors section of the Syros website at www.syros.com.
An archived replay will be available for approximately 30 days following
each presentation.

About Syros Pharmaceuticals
Syros Pharmaceuticals is
pioneering the understanding of the non-coding region of the genome to
advance a new wave of medicines that control expression of
disease-driving genes. Syros has built a proprietary platform that is
designed to systematically and efficiently analyze this unexploited
region of DNA in human disease tissue to identify and drug novel targets
linked to genomically defined patient populations. Because gene
expression is fundamental to the function of all cells, Syros’ gene
control platform has broad potential to create medicines that achieve
profound and durable benefit across a range of diseases. Syros is
currently focused on cancer and immune-mediated diseases and is
advancing a growing pipeline of gene control medicines. Syros’ lead drug
candidates are SY-1425, a selective RARα agonist in a Phase 2 clinical
trial for genomically defined subsets of patients with acute myeloid
leukemia and myelodysplastic syndrome, and SY-1365, a selective CDK7
inhibitor with potential in a range of solid tumors and blood cancers.
Led by a team with deep experience in drug discovery, development and
commercialization, Syros is located in Cambridge, Mass.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170301005221/en/